A Study of Botulinum Toxin A for Ultraviolet-Induced Hyperpigmentation: A Randomized Controlled Trial
BACKGROUNDUltraviolet (UV) exposure contributes to skin hyperpigmentation. Recently, botulinum neurotoxin type A (BoNT-A) showed a promising protective effect on UVB-induced hyperpigmentation in both in vitro and animal models.OBJECTIVEThe study aimed to investigate the preventive effect of BoNT-A a...
Saved in:
Main Authors: | Vasanop Vachiramon, Chaninan Kositkuljorn, Kanchana Leerunyakul, Teeraphong Rattananukrom, Natthachat Jurairattanaporn |
---|---|
Other Authors: | Faculty of Medicine Ramathibodi Hospital, Mahidol University |
Format: | Article |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/78239 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Study of botulinum toxin type A for the treatment of ultraviolet B-induced hyperpigmentation: A prospective, randomized, controlled trial
by: Natthachat Jurairattanaporn, et al.
Published: (2022) -
Incobotulinum Toxin Type A for Treatment of Ultraviolet-B-Induced Hyperpigmentation: A Prospective, Randomized, Controlled Trial
by: Vasanop Vachiramon, et al.
Published: (2022) -
Study of botulinum toxin type A for the treatment of ultraviolet B-induced hyperpigmentation: A prospective, randomized, controlled trial
by: Jurairattanaporn N.
Published: (2023) -
Isobutylamido thiazolyl resorcinol for prevention of UVB-induced hyperpigmentation
by: Vasanop Vachiramon, et al.
Published: (2020) -
Combined isobutylamido thiazolyl resorcinol and low-fluence Q-switched Nd: YAG laser for the treatment of facial hyperpigmentation: A randomized, split-face study
by: Vasanop Vachiramon, et al.
Published: (2020)